Effects of rhythm-control and rate-control strategies on cognitive function and dementia in atrial fibrillation: a systematic review and meta-analysis
- PMID: 38369630
- DOI: 10.1093/ageing/afae009
Effects of rhythm-control and rate-control strategies on cognitive function and dementia in atrial fibrillation: a systematic review and meta-analysis
Abstract
Background: Growing evidence suggests that atrial fibrillation (AF) is an independent risk factor for cognitive impairment and dementia, even in the absence of thromboembolic events and stroke. Whether rhythm-control therapy can protect cognitive function remains unclear. We aimed to evaluate the efficacy of rhythm-control strategies in patients with AF regarding cognitive function and dementia risk.
Methods: We systematically searched the PubMed, Embase and Cochrane Library databases for randomised clinical trials, cohort and case-control studies evaluating the associations between rhythm-control strategies and cognitive function outcomes up to May 2023. We assessed the risk of bias using the ROBINS-I and the Cochrane risk-of-bias tool. Both fixed- and random-effects models were used to create summary estimates of risk.
Results: We included a total of 14 studies involving 193,830 AF patients. In the pooled analysis, compared with rate-control, rhythm-control therapy was significantly associated with a lower risk of future dementia (hazard ratio (HR) 0.74; 95% confidence interval (CI) 0.62-0.89; I2 = 62%). Among the rhythm-control strategies, AF ablation is a promising treatment that was related to significantly lower risks of overall dementia (HR 0.62; 95% CI 0.56-0.68; I2 = 42%), Alzheimer's disease (HR 0.78; 95% CI 0.66-0.92; I2 = 0%) and vascular dementia (HR 0.58; 95% CI 0.42-0.80; I2 = 31%). Pooled results also showed that compared with patients without ablation, those who underwent AF ablation had significantly greater improvement in cognitive score (standardized mean difference (SMD) 0.85; 95% CI 0.30-1.40; P = 0.005; I2 = 76%).
Conclusions: Rhythm-control strategies, especially ablation, are effective in protecting cognitive function, reducing dementia risk and thus improving quality of life in AF patients.
Keywords: ablation; atrial fibrillation; cognitive function; dementia; older people; rhythm control; systematic review.
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis.J Gen Intern Med. 2021 Oct;36(10):3122-3135. doi: 10.1007/s11606-021-06954-8. Epub 2021 Jul 9. J Gen Intern Med. 2021. PMID: 34244959 Free PMC article.
-
Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review.J Interv Card Electrophysiol. 2022 Oct;65(1):271-286. doi: 10.1007/s10840-022-01196-y. Epub 2022 Apr 5. J Interv Card Electrophysiol. 2022. PMID: 35380337 Free PMC article. Review.
-
Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.JACC Clin Electrophysiol. 2024 Jul;10(7 Pt 1):1395-1405. doi: 10.1016/j.jacep.2024.03.006. Epub 2024 May 8. JACC Clin Electrophysiol. 2024. PMID: 38727662
-
Can catheter ablation reduce the incidence of thromboembolic events in patients with atrial fibrillation?: Protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2017 Dec;96(48):e8479. doi: 10.1097/MD.0000000000008479. Medicine (Baltimore). 2017. PMID: 29310330 Free PMC article.
-
Does atrial fibrillation cause cognitive decline and dementia?Europace. 2018 Mar 1;20(3):408-419. doi: 10.1093/europace/eux031. Europace. 2018. PMID: 28387847 Review.
Cited by
-
The role of atrial fibrillation in vascular cognitive impairment and dementia: epidemiology, pathophysiology, and preventive strategies.Geroscience. 2024 Aug 13. doi: 10.1007/s11357-024-01290-1. Online ahead of print. Geroscience. 2024. PMID: 39138793 Review.
Publication types
MeSH terms
Substances
Grants and funding
- 2022ZD0118005/National Key Research and Development Program of China
- Z201100005620010/Beijing Municipal Committee of Science and Technology
- 202112/Beijing Hospitals Authority Innovation Studio of Young Staff Funding Support
- 2023MP05/Beijing Tiantan hospital Miaopu Project
- Ministry of Finance of the People's Republic of China
LinkOut - more resources
Full Text Sources
Medical
